Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVENEW: EXOB-001 for Prevention of BPD in Preterm Newborns
NCT06279741Phase 2Recruiting
- Sponsor
- EXO Biologics
- Start
- Dec 2023
- Primary completion
- Jan 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 2
01
Overview
A Phase 2 trial of EXOB-001 in bronchopulmonary dysplasia (BPD), sponsored by EXO Biologics. Started Dec 2023; status: recruiting.
02
Drugs
EXOB-001
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT06279741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279741.